AVAV three-lens brief
Evidence-based stock research on AVAV. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +4.45% yesterday. · Trading at 4% of its 52-week range — deep in the lower band.
- Moved +4.45% yesterday.
- Trading at 4% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $226.50 — 54% above current (19 analysts).
AVAV closed at $147.06 (+4.45%) as of 2026-09-11. Market cap: $7.47B. Price is below the 50-day MA and below the 200-day MA. Positives: moved +4.45% yesterday.; analyst mean target $226.50 — 54% above current (19 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $480.49M, net income -$5.07M, free cash flow -$251.39M.
Why three lenses on AVAV, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AVAVacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AVAV" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AVAV brief"></iframe>